Ceryvyn Therapeutics Limited
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -193.5% | -193.5% | -154.6% |
| FY2023 | 2,435.0% | 2,435.0% | -144.5% |
| FY2024 | 290.5% | 290.5% | -116.7% |
| FY2025 | 81.0% | 81.0% | -286.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -193.5% | -193.5% | -154.6% |
| FY2023 | 2,435.0% | 2,435.0% | -144.5% |
| FY2024 | 290.5% | 290.5% | -116.7% |
| FY2025 | 81.0% | 81.0% | -286.6% |